Search results
Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends...Relapsed or...
Morningstar· 3 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma ...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 5 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Researchers discover promising approach to prevent recurrence of breast cancer
Medical Xpress· 16 hours agoA particular challenge in breast cancer treatment is the recurrence of the disease. The reasons why dormant breast cancer cells awake even after several years are not well understood. A Finnish ...
New Study Suggests Cancer Drug Could Be Used to Ta | Newswise
Newswise· 1 day agoIn studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1, a cell surface ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 20 hours agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters· 19 hours ago, opens new tab on Monday the U.S. Food and Drug Administration has placed a partial clinical hold...
The toxic truth about mouthwash
Daily Telegraph· 16 hours agoFor more than a decade, studies have suggested that mouthwash may raise the risk of some cancers. Interestingly, results also showed that the Listerine...
Pioneering studies show promise in sequencing a baby’s genome at birth
Washington Post· 1 day agoThe caller said she had news about the infant’s genome, the complex genetic code found in virtually...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 21 hours agoPreliminary data from the Phase I trial (NCT05838131) was shared during the 29th ... of the EHA,...